e-learning
resources
Madrid 2019
Monday, 30.09.2019
COPD treatment: cardiovascular, oxygen and vaccination studies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease
V. Antonov (Chelyabinsk, Russian Federation), G. Ignatova (Chelyabinsk, Russian Federation), E. Blinova (Chelyabinsk, Russian Federation), I. Grebneva (Chelyabinsk, Russian Federation), O. Rodionova (Chelyabinsk, Russian Federation)
Source:
International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Session:
COPD treatment: cardiovascular, oxygen and vaccination studies
Session type:
Thematic Poster
Number:
2467
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Antonov (Chelyabinsk, Russian Federation), G. Ignatova (Chelyabinsk, Russian Federation), E. Blinova (Chelyabinsk, Russian Federation), I. Grebneva (Chelyabinsk, Russian Federation), O. Rodionova (Chelyabinsk, Russian Federation). Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease. 2467
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Effectiveness of polysaccharide pneumococcal vaccination among subjects with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 442s
Year: 2006
Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 372s
Year: 2007
Prophylactic efficacy of pneumococcal vaccination for chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 178s
Year: 2006
Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 292s
Year: 2005
Effects of pneumococcal vaccine in patients with chronic respiratory disease
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
Effects of pneumococcal vaccine in patients with chronic respiratory disease
Source: Eur Respir Rev 2008; 17: 43-45
Year: 2008
Rate of flu vaccination in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 144s
Year: 2004
Clinical effect of different pneumococcal vaccination schedules in patients with chronic obstructive pulmonary disease (COPD): long-term follow-up results
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017
Results of vaccination against pneumococcal infection in patients with chronic lung diseases
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Pneumococcal vaccination coverage in Spanish patients with chronic obstructive pulmonary disease (COPD). Result of the EPIDEPOC study
Source: Eur Respir J 2004; 24: Suppl. 48, 144s
Year: 2004
Should chronic obstructive pulmonary disease patients must be vaccinated?
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
Effect of vaccination of pneumococcal infection on the course of chronic obstructive pulmonary disease in combination with diabetes mellitus
Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes
Year: 2019
Hospitalization for influenza among patients with chronic obstructive pulmonary disease
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Analysis of the Effect of pneumococcal vaccination in patients with COPD in combination with bronchiectasis
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021
Results of vaccination against pneumococcal infection in patients with chronic heart failure
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020
Does influenza vaccination increase consultations for corticosteroid prescriptions or exacerbations of asthma or chronic obstructive pulmonary disease?
Source: Annual Congress 2003 - COPD: risk factors and course of disease
Year: 2003
Chronic pulmonary diseases and the epidemiology of invasive pneumococcal infection
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
Predictors of influenza PCR positivity in acute exacerbations of chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era
Year: 2020
Association between influenza vaccination and the occurrence of acute exacerbation in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept